SEATTLE--(BUSINESS WIRE)--MitoPharm Corporation, Inc. (Pink Sheets:MTPM), announced today that Schisandrin B decreases the death rate of brain tissues that were subjected to oxidative challenge. The protective effect is mediated by the increase in antioxidant capacity of brain tissues.
